top of page

Reflux Disease: What We Are Doing, What We Could be Doing.

After viewing the webinar, please go to where you may log in and register. 
Once you have completed the test, you may download your certificate.


Given the high prevalence of gastroesophageal reflux disease (GERD) and the various complications which can result from inadequate treatment, it is important for practitioners to have a proper understanding of the current approach to its diagnosis and management. This presentation will review the pathophysiology of GERD and associated symptoms. Traditional and novel technologies to diagnose  GERD and Barrett’s esophagus will be discussed, along with the importance of pH monitoring as both a diagnostic and therapeutic modality. Lastly, the range of treatment options for chronic reflux will be discussed.


Learning Objectives:

Upon completion of this educational activity, the participant will be able to:

  1. Discuss the role of reflux and associated symptoms based on its effect of the end organ  

  2. Describe noninvasive procedures to diagnose Barrett’s Esophagus 

  3. Discuss the current interventional treatments  


Dr. Lankarani is a board-certified gastroenterologist from the American Board of Gastroenterology. He is a consultant at Borland Groover Clinic and a faculty member at Mayo Clinic and MD Anderson Cancer Center in Jacksonville, FL. Dr. Lankarani is a consultant for multiple gastroenterology device companies and collaborate in design and refinement of tools used in endoscopy. His is especially interested in endoscopic treatment of gastroesophageal reflux disease (GERD) and has been the lead investigator on the international multi-center study for endoscopic anterior fundoplication using MUSE system. His research interest mainly involves development of a new classification system used for personalized endoscopic treatment of GERD. 

Continuing Education for Physicians, Nurses, and Respiratory Therapists

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of SynAptiv and Saxe Healthcare Communications. SynAptiv is accredited by ACCME for 1 AMA PRA Category 1 Credit™. Continuing Respiratory Care Education (CRCE) credit by the American Association of Respiratory Care. This education activity is approved for 1.0 contact hour. Provider Saxe Healthcare Communications approved by California Board of Nursing, Provider # 14477 and the Florida Board of Nursing Provider # 50-17032.

bottom of page